Firm details
This firm has not yet provided any supplementary information. Please contact us for firm profiling options.
Key statistics
- Ranked Practice Areas
- 7
- Awards Won
- 2
- Recognised Lawyers
- 14
- Male:Female Ratio of Recognised Lawyers
- 11:3
Rankings
within Hong Kong
| Practice Area Subcategory | Index Rank | Ave. Tier | Table | ||
|---|---|---|---|---|---|
| Capital markets | |||||
| Debt | 1 | 1.0 | View full ranking table | ||
| Equity | 2 | 1.5 | View full ranking table | ||
| Corporate and M&A | |||||
| General | 3 | 2.0 | View full ranking table | ||
| Dispute resolution | |||||
| Arbitration | 8 | Notable | View full ranking table | ||
| General | 2 | 1.5 | View full ranking table | ||
| Financial services regulatory | |||||
| General | 1 | 1.0 | View full ranking table | ||
| Private equity | |||||
| General | 4 | 3.0 | View full ranking table | ||
| Regulatory | |||||
| General | 3 | 3.0 | View full ranking table | ||
| White collar crime | |||||
| Disputes | 1 | 1.0 | View full ranking table | ||
| General | 1 | 1.0 | View full ranking table | ||
Deals/Case awards
Total win-to-nominations ratio
2:26
| Award | Ratio |
|---|---|
| Capital markets - Debt | |
| Baidu $1 billion bonds issuance | 0:1 |
| CNPC offshore bond issuance | 0:1 |
| iQIYI offshore notes offering | 0:1 |
| Meituan S$2 billion senior note offering | 0:1 |
| Tencent Holdings senior notes and GMTN offering | 0:2 |
| Tencent Music $800 million SEC-registered notes offering | 0:3 |
| Capital markets - Equity | |
| Baidu $3.1 billion secondary listing on HKEX | 0:1 |
| Hepalink $532 million Hong Kong IPO | 0:1 |
| JOINN Laboratories global offering | 0:1 |
| KE Holdings $2.1 billion US IPO | 0:2 |
| Kingsoft Cloud $550 million US IPO | 0:1 |
| NetEase secondary listing on HKEX | 0:1 |
| Tigermed Hong Kong IPO | 0:2 |
| Corporate and M&A | |
| China Biologic Products $4.76 billion take-private | 1:2 |
| Huya / DouYu $6 billion merger | 0:1 |
| MBK Partners / CAR Inc acquisition | 0:1 |
| Tencent / Universal Music Group €6 billion strategic investment | 1:1 |
| Private equity | |
| China Biologic Products $4.76 billion take-private | 0:1 |
| Technology, media, telecoms | |
| Baidu $3.1 billion secondary listing on HKEX | 0:1 |
| Huya / DouYu $6 billion merger | 0:1 |
Firm awards
Total win-to-nominations ratio
0:10
| Award | Ratio |
|---|---|
| APAC regional awards | |
| Capital markets - Debt and equity | 0:1 |
| Capital markets - Structured finance, derivatives and securitisation | 0:1 |
| Dispute resolution - Arbitration | 0:1 |
| Financial services regulatory | 0:1 |
| White collar crime - Disputes | 0:1 |
| National awards | |
| Healthcare and life sciences | 0:1 |
| Technology, media, telecoms | 0:1 |
| Transactions | 0:1 |
| Practice management | |
| Diversity and inclusion firm of the year | 0:1 |
| Pro bono firm of the year | 0:1 |
Recognised lawyers
All data gathered from 2021 datasets. Learn more.